{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:43:37Z","timestamp":1770425017452,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-03859-9","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T14:20:44Z","timestamp":1737469244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Beyond LDL cholesterol: remnant cholesterol is associated with cardiometabolic risk factors in children"],"prefix":"10.1186","volume":"23","author":[{"given":"Ana","family":"Torres-Costoso","sequence":"first","affiliation":[]},{"given":"Vicente","family":"Mart\u00ednez-Vizca\u00edno","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Mairena","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Rodr\u00edguez-Guti\u00e9rrez","sequence":"additional","affiliation":[]},{"given":"Sergio N\u00fa\u00f1ez","family":"de Arenas-Arroyo","sequence":"additional","affiliation":[]},{"given":"Montserrat","family":"Solera-Mart\u00ednez","sequence":"additional","affiliation":[]},{"given":"Blanca","family":"Notario-Pacheco","sequence":"additional","affiliation":[]},{"given":"Vanessa","family":"Mart\u00ednez-Madrid","sequence":"additional","affiliation":[]},{"given":"Arthur Eumann","family":"Mesas","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"3859_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41569-021-00607-3","volume":"19","author":"N Townsend","year":"2022","unstructured":"Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, et al. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022;19:133\u201343.","journal-title":"Nat Rev Cardiol"},{"key":"3859_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00246-019-02152-w","volume":"40","author":"MG Abrignani","year":"2019","unstructured":"Abrignani MG, Luca F, Favilli S, Benvenuto M, Rao CM, Di Fusco SA, et al. Lifestyles and cardiovascular prevention in childhood and adolescence. Pediatr Cardiol. 2019;40:1113\u201325.","journal-title":"Pediatr Cardiol"},{"issue":"14","key":"3859_CR3","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/eurjpc\/zwad152","volume":"30","author":"H Hanssen","year":"2023","unstructured":"Hanssen H, Moholdt T, Bahls M, Biffi A, Siegrist M, Lewandowski AJ, et al. Lifestyle interventions to change trajectories of obesity-related cardiovascular risk from childhood onset to manifestation in adulthood: a joint scientific statement of the task force for childhood health of the European Association of Preventive Cardiology and the European Childhood Obesity Group. Eur J Prev Cardiol. 2023;30(14):1462\u201372.","journal-title":"Eur J Prev Cardiol"},{"key":"3859_CR4","doi-asserted-by":"publisher","first-page":"e024248","DOI":"10.1161\/JAHA.121.024248","volume":"11","author":"AJ Cupido","year":"2022","unstructured":"Cupido AJ, Asselbergs FW, Schmidt AF, Hovingh GK. Low-density lipoprotein cholesterol attributable cardiovascular disease risk is sex specific. J Am Heart Assoc. 2022;11:e024248.","journal-title":"J Am Heart Assoc"},{"key":"3859_CR5","doi-asserted-by":"publisher","first-page":"804214","DOI":"10.3389\/fcvm.2021.804214","volume":"8","author":"X Jin","year":"2022","unstructured":"Jin X, Yang S, Lu J, Wu M. Small, dense low-density lipoprotein-cholesterol and atherosclerosis: relationship and therapeutic strategies. Front Cardiovasc Med. 2022;8:804214.","journal-title":"Front Cardiovasc Med"},{"key":"3859_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/MED.0000000000000790","volume":"30","author":"NS Lan","year":"2023","unstructured":"Lan NS, Bell DA, Watts GF, Fegan PG. Lipid-lowering therapies, and cardiovascular risk-stratification strategies in adults with type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2023;30:103\u201312.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3859_CR7","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/ijms24021366","volume":"24","author":"R Fiorentino","year":"2023","unstructured":"Fiorentino R, Chiarelli F. Statins in children, an update. Int J Mol Sci. 2023;24:1366.","journal-title":"Int J Mol Sci"},{"key":"3859_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/joim.13059","volume":"288","author":"A Langsted","year":"2020","unstructured":"Langsted A, Madsen C, Nordestgaard B. Contribution of remnant cholesterol to cardiovascular risk. J Intern Med. 2020;288:116\u201327.","journal-title":"J Intern Med"},{"key":"3859_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2023.03.012","volume":"371","author":"XH Yang","year":"2023","unstructured":"Yang XH, Zhang BL, Cheng Y, Fu SK, Jin HM. Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: a systemic review and meta-analysis. Atherosclerosis. 2023;371:21\u201331.","journal-title":"Atherosclerosis"},{"key":"3859_CR10","first-page":"E645","volume":"11","author":"OR Weaver","year":"2023","unstructured":"Weaver OR, Krysa JA, Ye M, Vena JE, Eurich DT, Proctor SD. Nonfasting remnant cholesterol and cardiovascular disease risk prediction in Albertans: a prospective cohort study. Can Med Assoc J. 2023;11:E645\u201353.","journal-title":"Can Med Assoc J"},{"issue":"133\u2013139","key":"3859_CR11","first-page":"e131","volume":"232","author":"A Di Costanzo","year":"2021","unstructured":"Di Costanzo A, Perla FM, D\u2019Erasmo L, Arca M, Chiesa C, Pacifico L. Elevated serum concentrations of remnant cholesterol associate with increased carotid intima-media thickness in children and adolescents. J Pediatr. 2021;232(133\u2013139):e131.","journal-title":"J Pediatr"},{"key":"3859_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/er.2018-00184","volume":"40","author":"PB Sandesara","year":"2019","unstructured":"Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocrinol Rev. 2019;40:537\u201357.","journal-title":"Endocrinol Rev"},{"key":"3859_CR13","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.jacc.2022.03.384","volume":"79","author":"T Doi","year":"2022","unstructured":"Doi T, Langsted A, Nordestgaard BG. Elevated remnant cholesterol reclassifies risk of ischemic heart disease and myocardial infarction. J Am Coll Cardiol. 2022;79:2383\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"3859_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.ijo.0803738","volume":"32","author":"V Mart\u00ednez Vizca\u00edno","year":"2008","unstructured":"Mart\u00ednez Vizca\u00edno V, Salcedo Aguilar F, Franquelo Guti\u00e9rrez R, Solera Mart\u00ednez M, S\u00e1nchez L\u00f3pez M, Serrano Mart\u00ednez S, et al. Assessment of an after-school physical activity program to prevent obesity among 9-to 10-year-old children: a cluster randomized trial. Int J Obes. 2008;32:12\u201322.","journal-title":"Int J Obes"},{"key":"3859_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.recesp.2011.12.008","volume":"65","author":"V Mart\u00ednez-Vizca\u00edno","year":"2012","unstructured":"Mart\u00ednez-Vizca\u00edno V, S\u00e1nchez-L\u00f3pez M, Salcedo-Aguilar F, Notario-Pacheco B, Solera-Mart\u00ednez M, Moya-Mart\u00ednez P, et al. Protocol of a randomized cluster trial to assess the effectiveness of the MOVI-2 program on overweight prevention in schoolchildren. Rev Esp Cardiol (Engl Ed). 2012;65:427\u201333.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"9","key":"3859_CR16","doi-asserted-by":"publisher","first-page":"e14737","DOI":"10.1097\/MD.0000000000014737","volume":"98","author":"V Mart\u00ednez-Vizca\u00edno","year":"2019","unstructured":"Mart\u00ednez-Vizca\u00edno V, \u00c1lvarez-Bueno C, Cavero-Redondo I, Pozuelo-Carrascosa DP, Garrido-Miguel M, Mart\u00ednez-Hortelano JA, et al. MOVI-daFIT! Intervention: rationale and design of a cluster randomized controlled trial testing the effects on improving adiposity, cognition, and subclinical atherosclerosis by increasing cardiorespiratory fitness in children. Med. 2019;98(9):e14737.","journal-title":"Med"},{"key":"3859_CR17","doi-asserted-by":"crossref","unstructured":"Sequ\u00ed-Dom\u00ednguez I, Mart\u00ednez-Vizca\u00edno V, Rodr\u00edguez-Guti\u00e9rrez E, Bizzozero-Peroni B, Martinez-Madrid V, Prada de Medio E, et al. Association of daily steps on lipid and glycaemic profiles in children: the mediator role of cardiorespiratory fitness. Acta Paediatr. 2024;113:296\u2013302.","DOI":"10.1111\/apa.17035"},{"key":"3859_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137.","journal-title":"Lancet"},{"issue":"7","key":"3859_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"6","key":"3859_CR20","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.numecd.2021.02.034","volume":"31","author":"AF Cicero","year":"2021","unstructured":"Cicero AF, Fogacci F, Patrono D, Mancini R, Ramazzotti E, Borghi C, et al. Application of the Sampson equation to estimate LDL-C in children: comparison with LDL direct measurement and Friedewald equation in the BLIP study. Nutr Metab Cardiovasc Dis. 2021;31(6):1911\u20135.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"3859_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","volume":"5","author":"M Sampson","year":"2020","unstructured":"Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540\u20138.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"3859_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/02640418808729800","volume":"6","author":"LA Leger","year":"1988","unstructured":"Leger LA, Mercier D, Gadoury C, Lambert J. The multistage 20 metre shuttle run test for aerobic fitness. J Sports Sci. 1988;6(2):93\u2013101.","journal-title":"J Sports Sci"},{"key":"3859_CR23","volume-title":"Growth at adolescence","author":"JM Tanner","year":"1962","unstructured":"Tanner JM. Growth at adolescence. 2nd ed. Oxford: Blackwell Scientific Publications; 1962.","edition":"2"},{"issue":"1","key":"3859_CR24","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/ijo.2011.36","volume":"35","author":"A Lanfer","year":"2011","unstructured":"Lanfer A, Hebestreit A, Ahrens W, Krogh V, Sieri S, Lissner L, et al. Reproducibility of food consumption frequencies derived from the Children\u2019s Eating Habits Questionnaire used in the IDEFICS study. Int J Obes. 2011;35(1):S61\u20138.","journal-title":"Int J Obes"},{"issue":"4","key":"3859_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1089\/chi.2022.0073","volume":"19","author":"DP Pozuelo-Carrascosa","year":"2023","unstructured":"Pozuelo-Carrascosa DP, Mart\u00ednez-Vizca\u00edno V, Torres-Costoso A, Martinez MS, Rodr\u00edguez-Guti\u00e9rrez E, Garrido-Miguel M. \u201cFat but fit\u201d paradox and cardiometabolic risk in children: the role of physical activity. Child Obes. 2023;19(4):282\u201391.","journal-title":"Child Obes"},{"issue":"23","key":"3859_CR26","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/bjsports-2015-095903","volume":"50","author":"JR Ruiz","year":"2016","unstructured":"Ruiz JR, Cavero-Redondo I, Ortega FB, Welk GJ, Andersen LB, Mart\u00ednez-Vizca\u00edno V. Cardiorespiratory fitness cut points to avoid cardiovascular disease risk in children and adolescents; what level of fitness should raise a red flag? A systematic review and meta-analysis. Br J Sports Med. 2016;50(23):1451\u20138.","journal-title":"Br J Sports Med"},{"key":"3859_CR27","doi-asserted-by":"publisher","first-page":"830347","DOI":"10.3389\/fendo.2022.830347","volume":"13","author":"MM Chen","year":"2022","unstructured":"Chen MM, Huang X, Xu C, Song XH, Liu YM, Yao D, et al. High remnant cholesterol level potentiates the development of hypertension. Front Endocrinol. 2022;13:830347.","journal-title":"Front Endocrinol"},{"key":"3859_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jpeds.2021.01.019","volume":"232","author":"A Di Costanzo","year":"2021","unstructured":"Di Costanzo A, Perla FM, D\u2019Erasmo L, Arca M, Chiesa C, Pacifico L. Elevated serum concentrations of remnant cholesterol associate with increased carotid intima-media thickness in children and adolescents. J Pediatr. 2021;232:133\u20139.","journal-title":"J Pediatr"},{"issue":"6","key":"3859_CR29","first-page":"1887","volume":"45","author":"J Textor","year":"2016","unstructured":"Textor J, van der Zander B, Gilthorpe MS, Li\u015bkiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package \u2018dagitty.\u2019 Int J Epidemiol. 2016;45(6):1887\u201394.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"3859_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ije\/dyaa213","volume":"50","author":"PW Tennant","year":"2021","unstructured":"Tennant PW, Murray EJ, Arnold KF, Berrie L, Fox MP, Gadd SC, et al. Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations. Int J Epidemiol. 2021;50(2):620\u201332.","journal-title":"Int J Epidemiol"},{"issue":"24","key":"3859_CR31","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam CK, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285\u2013350.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3859_CR32","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.cjca.2022.05.002","volume":"38","author":"M Khoury","year":"2022","unstructured":"Khoury M, Bigras JL, Cummings EA, Harris KC, Hegele RA, Henderson M, et al. The detection, evaluation, and management of dyslipidemia in children and adolescents: a Canadian Cardiovascular Society\/Canadian Pediatric Cardiology Association clinical practice update. Can J Cardiol. 2022;38(8):1168\u201379.","journal-title":"Can J Cardiol"},{"key":"3859_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","volume":"29","author":"FL Visseren","year":"2022","unstructured":"Visseren FL, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. 2022;29:5\u2013115.","journal-title":"Eur J Prev Cardiol"},{"key":"3859_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3949\/ccjm.87a.19078","volume":"87","author":"M Mirbolouk","year":"2020","unstructured":"Mirbolouk M, Blaha MJ. ACC\/AHA lipid guidelines: personalized care to prevent cardiovascular disease. Cleve Clin J Med. 2020;87:231.","journal-title":"Cleve Clin J Med"},{"key":"3859_CR35","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","volume":"76","author":"O Casta\u00f1er","year":"2020","unstructured":"Casta\u00f1er O, Pint\u00f3 X, Subirana I, Amor AJ, Ros E, Hern\u00e1ez \u00c1, et al. Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol. 2020;76:2712\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"3859_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","volume":"290","author":"ENC Societies","year":"2019","unstructured":"Societies ENC, Mach F, Baigent C, Taskinen M-R. 2019 ESC\/EAS guidelines for the management of dyslipidemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140\u2013205.","journal-title":"Atherosclerosis"},{"key":"3859_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-017-0591-5","volume":"17","author":"JP Halcox","year":"2017","unstructured":"Halcox JP, Banegas JR, Roy C, Dallongeville J, De Backer G, Guallar E, et al. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. BMC Cardiovasc Disord. 2017;17:1\u201311.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"3859_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11883-022-00994-z","volume":"24","author":"CJ Packard","year":"2022","unstructured":"Packard CJ. Remnants, LDL, and the quantification of lipoprotein-associated risk in atherosclerotic cardiovascular disease. Curr Atheroscler Rep. 2022;24(3):133\u201342.","journal-title":"Curr Atheroscler Rep"},{"key":"3859_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","volume":"118","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118:547\u201363.","journal-title":"Circ Res"},{"issue":"1","key":"3859_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/joim.13059","volume":"288","author":"A Langsted","year":"2020","unstructured":"Langsted A, Madsen CM, Nordestgaard BG. Contribution of remnant cholesterol to cardiovascular risk. J Intern Med. 2020;288(1):116\u201327.","journal-title":"J Intern Med"},{"key":"3859_CR41","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","volume":"128","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128:1298\u2013309.","journal-title":"Circulation"},{"key":"3859_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-020-01076-7","volume":"19","author":"YX Cao","year":"2020","unstructured":"Cao YX, Zhang HW, Jin JL, Liu HH, Zhang Y, Gao Y, et al. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes. Cardiovasc Diabetol. 2020;19:1\u201310.","journal-title":"Cardiovasc Diabetol"},{"key":"3859_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-022-01554-0","volume":"21","author":"X Hu","year":"2022","unstructured":"Hu X, Liu Q, Guo X, Wang W, Yu B, Liang B, et al. The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus. Cardiovasc Diabetol. 2022;21:1\u201310.","journal-title":"Cardiovasc Diabetol"},{"key":"3859_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/nu12020415","volume":"12","author":"P Arellano-Ruiz","year":"2020","unstructured":"Arellano-Ruiz P, Garc\u00eda-Hermoso A, Garc\u00eda-Prieto JC, S\u00e1nchez-L\u00f3pez M, Mart\u00ednez-Vizca\u00edno V, Solera-Mart\u00ednez M. Predictive ability of waist circumference and waist-to-height ratio for cardiometabolic risk screening among Spanish children. Nutrients. 2020;12:415.","journal-title":"Nutrients"},{"key":"3859_CR45","doi-asserted-by":"publisher","first-page":"929560","DOI":"10.3389\/fcvm.2022.929560","volume":"9","author":"J Tong","year":"2022","unstructured":"Tong J, Li X, Liang X, Tang F, Ren Y, Hao G, et al. The relationship of remnant cholesterol and abdominal obesity in children: a cross-sectional study. Front Cardiovasc Med. 2022;9:929560.","journal-title":"Front Cardiovasc Med"},{"key":"3859_CR46","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","volume":"42","author":"R Quispe","year":"2021","unstructured":"Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021;42:4324\u201333.","journal-title":"Eur Heart J"},{"issue":"9","key":"3859_CR47","doi-asserted-by":"publisher","first-page":"913869","DOI":"10.3389\/fcvm.2022.913869","volume":"17","author":"K Wang","year":"2022","unstructured":"Wang K, Wang R, Yang J, Liu X, Shen H, Sun Y, et al. Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment. Front Cardiovasc Med. 2022;17(9):913869.","journal-title":"Front Cardiovasc Med"},{"issue":"34","key":"3859_CR48","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FL Visseren","year":"2021","unstructured":"Visseren FL, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2021;42(34):3227\u201337.","journal-title":"Eur Heart J"},{"issue":"3","key":"3859_CR49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jama.2023.8867","volume":"330","author":"JM Guirguis-Blake","year":"2023","unstructured":"Guirguis-Blake JM, Evans CV, Coppola EL, Redmond N, Perdue LA. Screening for lipid disorders in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2023;330(3):261\u201374.","journal-title":"JAMA"},{"key":"3859_CR50","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/1520-6300(200102\/03)13:2<227::AID-AJHB1033>3.0.CO;2-K","volume":"13","author":"SD Cho","year":"2001","unstructured":"Cho SD, Mueller WH, Meininger JC, Liehr P, Chan W. Blood pressure and sexual maturity in adolescents: the Heartfelt Study. Am J Hum Biol. 2001;13:227\u201334.","journal-title":"Am J Hum Biol"},{"key":"3859_CR51","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ejcn.2011.222","volume":"66","author":"A Spinneker","year":"2012","unstructured":"Spinneker A, Egert S, Gonz\u00e1lez-Gross M, Breidenassel C, Albers U, Stoffel-Wagner B, et al. Lipid, lipoprotein and apolipoprotein profiles in European adolescents and its associations with gender, biological maturity, and body fat\u2014the HELENA Study. Eur J Clin Nutr. 2012;66:727\u201335.","journal-title":"Eur J Clin Nutr"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03859-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-03859-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03859-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T15:00:02Z","timestamp":1737471602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-03859-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3859"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-03859-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee for Clinical Research of the Virgen de la Luz Hospital in Cuenca approved the study protocols (MOVI study: SAN03060-00; MOVI-2 study: PI081297; MOVI-da-Fit study: PI0216; e-MOVI study: P11519). In accordance with the Declaration of Helsinki, legal guardians were asked to sign informed consent forms allowing their children to participate. Participants\u2019 privacy and confidentiality were ensured.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}